The Research Ethics Evolution: from Nuremberg to Helsinki
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Review of Scientific Self-Experimentation: Ethics History, Regulation, Scenarios, and Views Among Ethics Committees and Prominent Scientists
Rejuvenation Research Page 1 of 41 © Mary Ann Liebert, Inc. DOI: 10.1089/rej.2018.2059 1 Review of Scientific Self-experimentation: ethics history, regulation, scenarios, and views among ethics committees and prominent scientists. Brian Hanley, Butterfly Sciences, POBox 2363, Davis, CA 95616, USA. [email protected] William Bains, Rufus Scientific Ltd. 37 The Moor, Melbourn, Royston, Hertsfordshire, SG8 nt scientists. (DOI: 10.1089/rej.2018.2059) 10.1089/rej.2018.2059) scientists. nt (DOI: 6ED, UK. [email protected] nal published version may fromdiffer this proof. George Church, Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. Word count: 5,969 Address for correspondence and reprints: [email protected] Keywords: ethics, research history, human research, medical ethics; self-experimentation, n-of-1 Abbreviated title: Review of Scientific Self-experimentation Rejuvenation Research lation, scenarios, and views among ethics committees and promine Downloaded by UNIVERSITY OF FLORIDA from www.liebertpub.com at 06/25/18. For personal use only. Review of Scientific Self-experimentation: regu ethics history, This paper has been peer-reviewed and accepted publication,for but has yet to copyediting undergo correction. and proof The fi Page 2 of 41 2 Abstract We examine self-experimentation ethics history and practice, related law, use scenarios in universities and industry, and attitudes. We show through analysis of the historical development of medical ethics and regulation, from Hippocrates through Good Clinical Practice that there are no ethical barriers to self-experimentation. When the self- experimenter is a true investigator, there is no other party to be protected from unethical behavior. -
Informed Consent and Shared Decision Making in EBM
3 Informed Consent and shared decision making in EBM 3.1 ‘Informed consent’ in regular medical practice ‘Consent’ as it is understood in the medical context has to be asked from the pa- tient and is the explicit agreement to waive a right to certain rules and norms which are normally expected in the treatment of other people and of ourselves as patients. Every surgical procedure would, without consent from the patient, be legally un- derstood as assault and battery and the physician could be prosecuted for perform- ing it. ‘Informed consent’ therefore in its most simple form means that the patient has received a good explanation about a medical procedure, understands what is happening to him or her and then can make an informed choice to accept or refuse, in the latter case the so called ‘informed refusal.167 In order to give ‘informed con- sent the patient has to be capable of understanding the information given by the physician. He or she must be competent to decide and to give consent voluntarily without being coerced by any means into giving consent.168 ‘Autonomy’ of the patient, hereby equated with ‘person’ plays the overarching role in ‘informed con- sent.’ A competent person who exercises autonomy will have the final say about their own life. ‘Autonomy’ itself is a contested term in the philosophy of science and interpretations therefore vary. According to Dworkin, “Liberty (positive or negative) ... dignity, integrity, individuality, independence, responsibility and self knowledge ... self assertion ... critical reflection ... freedom from obligation ... ab- sence of external causation ... and knowledge of one’s own interests.”169 all fall under the definition of autonomy. -
Informed Consent and Refusal
CHAPTER 3 Informed Consent and Refusal Evolution of the doctrine of informed consent Elements of informed consent and refusal The nature of informed consent Exceptions to the consent requirement Mrs. Stack is a 67- year- old woman admitted with rectal bleeding, chronic renal in- sufficiency, diabetes, and blindness. On admission, she was alert and capacitated. Two weeks later, she suffered a cardiopulmonary arrest, was resuscitated and intu- bated, and was transferred to the medical intensive care unit (MICU) in an unrespon- sive and unstable state. Consent for emergency dialysis was obtained from her son, who is also her health care agent. Dialysis was repeated two days later. During the past several years, Mrs. Stack has consistently stated to her family and her primary care doctor that she would never want to be on chronic dialysis and she has refused it numerous times when it was recommended. The physician, who has known and treated Mrs. Stack for many years, also treated her daughter who had been on chronic dialysis for some time and had died after suffering a heart attack. According to the physician and the patient’s family, Mrs. Stack’s refusal of dialysis has been based on her conviction that her daughter died as a result of the dialysis treatments. Mrs. Stack’s mental status has cleared considerably and, despite the ventilator, she is able to communicate nonverbally. Although she appears to understand the benefits of dialysis and the consequences of refusing it, including deterioration and eventual death, she has consistently and vehemently refused further treatments. Her capacity to make this decision is not now in question. -
Ethics for Researchers
Ethics for researchers Facilitating Research Excellence in FP7 Research and Innovation EUROPEAN COMMISSION Directorate-General for Research and Innovation Directorate B – European Research Area Unit B.6 – Ethics and gender Contact: Isidoros Karatzas European Commission B-1049 Brussels E-mail: [email protected] [email protected] EUROPEAN COMMISSION Ethics for researchers Facilitating Research Excellence in FP7 Directorate-General for Research and Innovation 2013 Science in society /Capacities FP7 EUROPE DIRECT is a service to help you find answers to your questions about the European Union Freephone number (*): 00 800 6 7 8 9 10 11 (*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed LEGAL NOTICE Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information. The views expressed in this publication are the sole responsibility of the author and do not necessarily reflect the views of the European Commission. More information on the European Union is available on the Internet (http://europa.eu). Cataloguing data can be found at the end of this publication. Luxembourg: Publications Office of the European Union, 2013 ISBN 978-92-79-28854-8 doi 10.2777/7491 © European Union, 2013 Reproduction is authorised provided the source is acknowledged. Cover Image © Sergey Nivens, #49108932, 2013. Source: Fotolia.com. Table of Contents Introduction ..................................................................................................................... -
(IRBS) and the Globalization of Clinical Research: Can Ethical Oversight of Human Subjects Research Be Standardized?
Washington University Global Studies Law Review Volume 15 Issue 2 2016 Research Ethics Committees (RECS)/Institutional Review Boards (IRBS) and the Globalization of Clinical Research: Can Ethical Oversight of Human Subjects Research be Standardized? Andrea S. Nichols Follow this and additional works at: https://openscholarship.wustl.edu/law_globalstudies Part of the Biochemistry, Biophysics, and Structural Biology Commons, Bioethics and Medical Ethics Commons, Health Law and Policy Commons, Laboratory and Basic Science Research Commons, Medical Jurisprudence Commons, and the Science and Technology Law Commons Recommended Citation Andrea S. Nichols, Research Ethics Committees (RECS)/Institutional Review Boards (IRBS) and the Globalization of Clinical Research: Can Ethical Oversight of Human Subjects Research be Standardized?, 15 WASH. U. GLOBAL STUD. L. REV. 351 (2016), https://openscholarship.wustl.edu/law_globalstudies/vol15/iss2/8 This Note is brought to you for free and open access by the Law School at Washington University Open Scholarship. It has been accepted for inclusion in Washington University Global Studies Law Review by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. RESEARCH ETHICS COMMITTEES (RECS)/INSTITUTIONAL REVIEW BOARDS (IRBS) AND THE GLOBALIZATION OF CLINICAL RESEARCH: CAN ETHICAL OVERSIGHT OF HUMAN SUBJECTS RESEARCH BE STANDARDIZED? INTRODUCTION Current United States’ policy requires federally funded research studies involving human subjects to be approved by an interdisciplinary committee called an institutional review board (IRB).1 IRBs exist to protect the safety and welfare of human subjects participating in research studies. Although oversight of human subjects research and, consequently, IRBs, is governed by federal regulations, the operation of IRBs remain largely mysterious to those other than IRB members themselves. -
Protecting Human Research Participants NIH Office of Extramural Research Introduction
Protecting Human Research Participants NIH Office of Extramural Research Introduction Research with human subjects can occasionally result in a dilemma for investigators. When the goals of the research are designed to make major contributions to a field, such as improving the understanding of a disease process or determining the efficacy of an intervention, investigators may perceive the outcomes of their studies to be more important than providing protections for individual participants in the research. Although it is understandable to focus on goals, our society values the rights and welfare of individuals. It is not considered ethical behavior to use individuals solely as means to an end. The importance of demonstrating respect for research participants is reflected in the principles used to define ethical research and the regulations, policies, and guidance that describe the implementation of those principles. Who? This course is intended for use by individuals involved in the design and/or conduct of National Institutes of Health (NIH) funded human subjects research. What? This course is designed to prepare investigators involved in the design and/or conduct of research involving human subjects to understand their obligations to protect the rights and welfare of subjects in research. The course material presents basic concepts, principles, and issues related to the protection of research participants. Why? As a part of NIH's commitment to the protection of human subjects and its response to Federal mandates for increased emphasis on protection for human subjects in research, the NIH Office of Extramural Research released a policy on Required Education in the Protection of Human Research Participants in June 2000. -
NACO Ethical Guidelines for Operational Research
ETHICAL GUIDELINES FOR OPERATIONAL RESEARCH ON HIV/AIDS Version 2008 NATIONAL AIDS CONTROL ORGANISATION Ministry of Health & Family Welfare, Government of India CONTENTS 1. Introduction 1.1 Preamble 1.2 Basic Responsibility of the Ethics Committee 1.3 Composition of NACO Ethics Committee 1.4 Terms of Reference of Members 2. Principles for Ethical Issues 2.1 General Principles for Ethical Issues 2.2 Specific Principles 2.2.1 Informed consent of Participants 2.2.2 Essential Information for prospective research participants 2.2.3 Confidentiality for prospective research participants 2.2.4 Conflicts of Interest 2.2.5 International collaboration/assistance in Evaluation and Operational Research 2.2.6 Special Concerns 3. Researcher‟s relations with the media and publication practices 4. Ethical Issues in Epidemiological Research 5. Distinction between research and program evaluation 6. Community participation 7. Ethical Issues in Questionnaire based research 8. Ethical Issues in Focus Group Discussion 9. Ethical Issues in Internet Based Research 10. Procedure for Ethical Review of Proposals 11. Submission of Application 12. Decision making process 13. Review Process APPENDIX: Appendix A: Application Form 2 1. INTRODUCTION 1.1 Preamble NACO Ethics Committee for Research is constituted with responsibility to ensure that the ethical implications of any research undertaken are afforded serious consideration prior to the commencement of a project and that such research is consistent with legislative and statutory requirements. The rationale for ethical approval is to ensure that the process of research is conducted „ethically‟ and responsibly and ensures protection of privacy and not exploitative of participants. This mainly involves establishing procedures for the informed consent of those subjects involved in research, as well as appropriate handling of the research findings (e.g. -
Biobank Regulation in Finland and the Nordic Countries
Biobank Regulation in Finland and the Nordic Countries By Dr. Salla Silvola, University of Helsinki l 1 The biobank as a concept The term biobank, or biopankki, in Finnish, is not used in everyday life in Finland. Neither does the concept of the biobank appear in the existing legislation in Fin- land.2 The word itself refers to the storing of biological material. As it does not di- rectly refer to any research activities, the average layman could easily mistake its purposej guesses can range from collections of rare plants to human organ banks. However, the word is commonly used amongst Nordic biomedical researchers, and has been in use in the ethico-Iegal debate since the mid-1990S, although there is no Single universal definition for it even in this forum} Biobanks may be established not only for research, but also, for example, for patient safety, quality assurance, trans- plantation, assisted procreation, or for manufacturing medicinal products. Many biobanks have been set up for a combination of purposes.4 For present purposes, I will refer to a biobank as a collection of human biological samples combined with health and lifestyle information on the provider of the sam- ple.S The information mayor may not be linked to an identifiable person (personal data), and the information mayor may not contain genetic information. 1 Dr. Salla Silvola (fonnerly Salla L6tjonen) works as Senior Advisor in Legislative Affairs in the Ministry ofJustice, Finland. She is also a Docent in Medical and Bio Law and teaches part-time at the Faculty of Law at the University of Helsinki. -
Position on Physician Participation in Torture
Society of General Internal Medicine Position on Physician Participation in Torture 2018 Prepared by Carolyn Kreinsen, P. Preston Reynolds, Katherine McKenzie, Tom Comerci, Oliver Fein on behalf of Global Health and Human Rights Interest Group, Ethics Committee, and Health Policy Committee The Society of General Internal Medicine resolves that health care professionals, with a specific focus on physicians, • Shall not knowingly provide any research, instruments, or knowledge that facilitates the practice of torture or other forms of cruel, inhuman, or degrading treatment or cruel, inhuman, or degrading punishment; • Shall not knowingly participate in any procedure in which torture or other forms of cruel, inhuman, or degrading treatment or punishment is used or threatened; • Shall attempt to stop torture or other cruel, inhuman, or degrading treatment or punishment, where a health care professional is present, and failing that, exit the procedure; • Shall be alert to acts of torture and other cruel, inhuman, or degrading treatment or punishment and have the ethical responsibility to report these acts to the appropriate authorities. • Shall not participate in interrogation of detainees. This includes providing medical clearance for interrogation, treating or reviving interrogates during questioning, monitoring interrogations or helping design interrogations(1) • Shall not force feed detainees participating in voluntary protest fasting (“hunger strikes”)(2-5) The Society of General Internal Medicine believes the Department of Defense should • ensure that military health care provider’s first ethical obligation is to the patient. • excuse health care professionals from performing medical procedures that violate their professional code of ethics (6) • implement the recommendations of the Defense Health Board Ethics Subcommittee related to training of military health professionals in concepts of dual loyalty and ethics of combat to ensure maintenance of high ethical standards of health professionals in the field of operation. -
International Compilation of Human Research Standards 2017 Edition
International Compilation of Human Research Standards 2017 Edition Compiled By: Office for Human Research Protections U.S. Department of Health and Human Services PURPOSE The International Compilation of Human Research Standards enumerates over 1,000 laws, regulations, and guidelines that govern human subjects research in 126 countries, as well as standards from a number of international and regional organizations. This Compilation was developed for use by researchers, IRBs/Research Ethics Committees, sponsors, and others who are involved in human subjects research around the world. Content experts from around the world, listed at the back of the Compilation, provided updates (or confirmations of prior listings), which are reflected in the hundreds of changes entered in this Edition. Six new countries are featured in the 2017 Edition: Benin, Bermuda, Democratic Republic of the Congo, Dominican Republic, Guyana, and Senegal. The countries of the Middle East are now found in a separate section beginning on page 136. ORGANIZATION The Table of Contents is on pages 3-4. For each country, the standards are categorized by row as: 1. General, i.e., applicable to most or all types of human subjects research 2. Drugs and Devices 3. Clinical Trial Registries 4. Research Injury 5. Privacy/Data Protection (also see Privacy International reports: https://www.privacyinternational.org/reports) 6. Human Biological Materials 7. Genetic (also see the HumGen International database: http://www.humgen.umontreal.ca/int/) 8. Embryos, Stem Cells, and Cloning These eight categories often overlap, so it may be necessary to review the other standards to obtain an accurate understanding of the country’s requirements. -
Case Study Guidelines
CASE STUDIES Note to the Facilitator The Case Studies section provides 10 health-research case studies to prompt discussion about the material presented in the curriculum. Case Studies in the Curriculum Case Study 1: Principles of Research Ethics (slide 13) Case Study 2: Informed Consent (slide 46) Case Study 3: Research Ethics Committee Considerations (slide 57) Case Study 4: Community Participation (slide 77) Additional Case Studies Case Study 5: Inducement/Compensation Case Study 6: Social Risks Case Study 7: Respect for Persons Case Study 8: Beneficence and Justice Case Study 9: Individual versus Community Consent Case Study 10: Research Involving Minors The case studies are based on real-life research studies conducted throughout the world. They illustrate the complexity of human research and how cultural, social, and gender issues impact the ethics of a research study. The issues that are raised transcend any specific category of research and were selected to elicit a variety of reactions. This type of discussion will enrich the training group and should be pursued. The facilitator might find that discussion becomes so absorbing that he or she will need to curtail it in the interest of time. We believe that these case studies are applicable to most geographic settings, but discussions of characteristics that are unique to a particular country are encouraged. Discussing the Case Studies • The ideal way to discuss the case studies is to divide the participants into groups of eight and have them sit around group tables, round tables being preferred. Ask the groups to pretend to be formally established Research Ethics Committees. -
Ethical Considerations in Treatment and Research in Spinal Injuries
ETHICAL CONSIDERATIONS IN TREATMENT AND RESEARCH IN SPINAL INJURIES By Dr. H. L. FRANKEL National Spinal Injuries Centre, Stoke Mandeville Hospital, Aylesbury, England As specialists in spinal injuries we take our teaching on ethics from the main stream of medical opinion. The portion of the Hippocratic Oath relevant to today's discussion in an English version is 'I will use treatment to help the sick according to my ability and judgement, but never with a view to injury or wrong-doing'. Medical ethics throughout the world were based to a greater or lesser extent on the Hippocratic Oath, depending on local customs. Following World War II and the Nuremberg War Crimes Commission, the World Health Organisation set up a commission in Paris in 1947 which was extended and became the Declaration of Geneva 1948 (fig. 1). This is very similar to the Hippocratic Oath and is of a very general nature. DECLARATION OF GENEVAl 'At the time of being admitted as a member of the Medical Profession: I solemnly pledge myself to consecrate my I ife to the service of humanity. I will give to my teachers the respect and gratitude which is their due; I will practise my profession with conscience and dignity; The health of my patient will be my first consideration; I will respect the secrets which are confided to me; I will maintain by all the means in my power, the honour and the noble traditions of the medical profession; My colleagues will be my brothers; I will not permit considerations of religion, nationality, race, party politics or social standing to intervene between my duty and my patient; I will maintain the utmost respect for human life, from the time of conception; even under threat, I will not use my medical knowledge contrary to the laws of humanity.